Get started

Pennystocks

BLUE- a biotechnology earnings penny stock LONGBLUE a week ago had a bull run to gain 90% in 5 days and then reversed into a standard Fibonacci retracement on the 30-minute chart, then in consolidation for a day or two getting support from the mean anchored VWAP. The last trading day was a quick rise with momentum in a bull flag. Earnings are coming. I will take another long trade on BLU into earnings. My target is 1.90 about the high of the prior trend up and below the second VWAP line above the mean. A tight stop loss at 1.53 ( below the flag's consolidation) will make it more likely the trade will be a 20% winner. I have taken call options strikng $1.50 for March 15th for $20 each. or a small loss of 2-3%
NASDAQ:BLUELong
by AwesomeAvani
MYO can Myomo continue the push to the earnings report?MYO had impressive week gaining over 35%. It is a volatile penny biotechnology stock with good earnings back in November new due for another report. On a 120 minute chart with relative volatility and volume indicators and a volume profile added. The volume and volativlty of this past week's move is obvious. Price gain has slowed on the approach to the POC line of the volume profile which appears to be resistance. Price may break that resistance but could get rejected there. I plan to buy MYO long on a break of resistance with a buy stop set at 4.04 and a stop loss at 3.96. If MYO rises and gets over 4.04 the order should fill and if it retests the POC line as support and the support fails, the stop will close the trade. My expectation however is for the earnings run to take it to the level of the pivot high in early January for a 25% gain.
AMEX:MYOLong
by AwesomeAvani
EXFY a fintech penny stock at 5% of the ATH LONGEXFY recently had an earnings beat and has bullish momentum. While on a sixty minute chart it may appear to be overextended, in the context of an all-time-high of about $50 perhaps it has as much as 20X upside. EXFY rose from the earnings beat and then retraced and reversed the retracement. I see it as a long wing trade perhaps until the approach to the next earnings. The volume and volatility indicators suggest bullish momentum is strong and may continue.
NASDAQ:EXFYLong
by AwesomeAvani
10
LEXX a penny medical stock LONGLEXX on the daily chart is on a big bullrun breaking out of an ascending broadening triangle or megaphone pattern demostrative of increasing volatility. Retlative volumes are 2X the historical comparison. Price is now on the approach to the highs of 2023 but is only 15% of the all high highs of 19 at the neckline of a head and shoulders back in 2018-2019, In short it has a lot of upside if it can show earnings growth on higher revenues. For now targets are 4.15 the high of 2022 and 6.45 the high of 2021 marked on the chart in black horizontal lines. LEXX is a money burning medical penny it is high risk like its peers. The reward potential is as much as 7X and more realistically 2X in the intermediate term. I will so long here with the risk in mind in the context of the reward potential.
NASDAQ:LEXXLong
by AwesomeAvani
FSR is driving to its earnings LONGFSR is shown here on a 30 minute chart on the move up in the approach to earnings on February 29th. For comparison purposes only TSLA is shown sideways with the purple line. FSR has started a VWAP band breakout into the area of the mean anchored VWAP where it could pick up institutionally based trader interest. The growing volumes of trading are obvious and lend further support to taking a position. I will long long here with both shares and options as a pre-earnings play. The call options for mid-March are $ 6.00 per contract.
FLong
by AwesomeAvani
8
MYO a Stock I randomly pulled up and conducted some R/AR/A = Research and Analysis This stock just randomly chose to after looking at a few robotics stock. I went through a few stocks to show how I conduct my R/A and wanted to see if I could find some ideas and themes to trade. A stock that got selected was MYO. MYO is a company that sells robotic arms to people regain function in their arms and hands. Their product is called MyoPro. This stock might be able to push higher in the longer term (maybe in 2025). The technicals are not good on it. The fundamentals aren't also. And there is almost no sentiment on this stock because there is close to 0% PR on here, expect some articles talk about price movement. But, something that I saw that caught my eye is an individual in Australia used their product, was able to get their function back, and was able to benefit from the Nation Disability Insurance Scheme (NDIS) in Australia. Another that caught my eye is they are attempting to get their product approved for claims for Medicare Part B beneficiaries. If this is approved, the stock might be able to push above the $1 lvl and maybe push above the $2. So, this stock might have some promise. For now, I wouldn't get in because of the state of the economy, high inflation, and rates increasing. There are also the negatives aside from this stock almost collapsing, which is it's competitors and technologies such as Neuralink from Elon Musk. I am not in this stock and highly likely I won't get in. This is just some research I have done and I am seeing where price is going to move and to see if I am correct.
AMEX:MYOLong
by DollarSaenz
2
Novavax- NVAX- Medical Technology Vaccine Focused LONGNVAX on the 15 minute chart has been compressing price action volatility into a symmetrical triangle. It in now in a breakout of the triangle and in the process when from undervalued on Monday to the upper trendline and then down to the support trendline and then up again. It passed through the volume profile and its high volume area. In short, it has bullish momentum capped off with a breakout from the high volume area into a bullflag to rest the weekend. I am in this stock going and now is an opportunity to add to the position. If a trader wants to know what I consider to be targets upside, let me know. Medical technology is expected to be among the hottest of subsectors for 2024. NVAX has been beaten down. I believe it has significant upside for the long term. in the short term, earnings are expected on February 28th so this is a trade to consider on that run up. Call options for March 2 or March 16 can be considered.
NASDAQ:NVAX
by AwesomeAvani
UCAR a penny China stock now at bottom 300X upside LONGUCAR, a NASDAQ penny stock and a Chinese auto dealership enterprise is experiencing a huge relative volume spike. UCAR had a great week in very active trading. Now priced at about 0.07 per share, my near term target is 1.58 representing a consolidation pivot on the chart. The all time high is the is 300X upside more or less. This is a risky play. It could get delisted although NASDAQ will give it some more quarterly reports to make a case for regulatory compliance and stock price stability I will take a small position here given the risk. Warren Buffet got in on the cheap with BYD over the counter, he has been massively rewarded for his very large position. Retail traders can make good profits with undervalued penny stocks. I think that this right now is one of them. I will use a zig zag strategy to take profits at high pivots and add into the position at low pivots along the way.
NASDAQ:UCARLong
by AwesomeAvani
2
SRZN great trend up this year then pullback can be bought LONGSRZN ona 30 minute chart is on a consistent trend up for three weeks with some minor normal corrections while underway. Now is one of those pullbacks waiting for an entry. Price is getting support from the first upper VWAP bandline confluent with the lower ascending support line of the megaphone pattern. A megaphone pattern documents increasing volatility in the price action. Volatility is profitable in trading the swings as a swing trade or even intraday. I will take a long trade here targeting the top of the pattern or about going from 12 to 15 being 25% upside.
NASDAQ:SRZNLong
by AwesomeAvani
SOUN might be overbought and overvalued for a reversalSOUNDHound AI on the 15 minute on Wednesday 60 hours ago, broke out after a trend down to begin the year. The tailwinds of the technology stock earnings and their tailwinds pushed hard. SOUN broke out through the entire high volume area and then rose above it. Pretty much the same from the lower aVWAP bands into the uppers after crossing over the mean line. On the three indicators, RSI , MACD and the Chop index bearish diveragence is seen. This may be an early reversal in progress but then again it might just be prudent traders liquidating to take full or partial profits to close out the week. I am running full on this, I will watch the price action early next week to determine a continuation vs a reversal. Relative volume and relative volatility may show long traders closing with targets reached and shorts taking their positions causing a pivot high of even a " long squeeze". Alerts and their notifications are set on a 5-minute time frame to allow for some early warning. On the other hand it SOUN can put out some higher decibels I may decide to look at the 2/16 options chain and chart for an OTM call in the $2.5 or $3 range.
NASDAQ:SOUNLong
by AwesomeAvani
4
Can WIMI an IT penny stock hold above a dollar per share ?WIMI rocketed from 60 cents to $1.50 two days ago and then fell to 93 cents near to the Fib 0.62 retracement which is greater than the typical. The idea is on the chart. So the analysis is a symmetrical triangle pattern with a high normal retracement now at the apex of the triangle with quick compression on the 15 minute chart. Volume is now. Friday afternoon had a pullback likely to rake profit for the weaken. Money flow and relative strength are decent but settled down. So will this penny awke up next week and try to move toward its high of the week or will it fall lacking attention from distraction by technology stock earnings reports and a crypto-sruge. To be sure, this is not an earnings play. There was a highly significant news catalyst early in the week. This news is a possilbe game changer. Over the intermediate term, despite any analysts' forecasts this could do 10X by summer. As to next week, who knows but with an overshoot on the retracement and now below the the mean VWAP band anchored to the beginning of the week. I am voting for a reversion to the mean which just happens to be 1.00 ( a convenient "psychological level.). As to a trade setup, a will take a big lot of shares from a buy stop set for 1.01 with a stop loss of 0.97 and see if I get filled.No matter, this will be a swing trade for me. I will do adds at the low of the week each week for several. I understand the news catalyst and believe this penny IT will get a begin growth spurt in little time at all.
NASDAQ:WIMILong
by AwesomeAvani
$CGAC Bitcoin Mining Company with 722 Miners Increasing to 1,500Bitcoin is on the move once again and cracked past $50,000 today a pivotal mental barricade that hasn't been broken in several years since the bear market started and ended and the bull market began. Bitcoin Stocks that mine usually do the best during the crypto bull cycle and the best and lowest of them all at the moment is OTC:CGAC Currently the company is in the process of increasing their miners from 722 to 1,500 in the short term and will also be doing a CUSIP and Name Change in the coming weeks to accommodate its business direction. There is sufficient gains to be made here as it did do .05 last time around, and this time, with sufficient interest in the Crypto market we could very well see .10+ I am very bullish on this one.
OTC:CGACLong
by StockGuild
GTL INTRASTRUCTURE - BEST PERFORMER PENNY STOCKCan enter at CMP 1.75 or Enter at 1.60 level Targets - 2.35,3.75+ Disclaimer - All information on this page is for educational purposes only, we are not SEBI Registered, Please consult a SEBI registered financial advisor for your financial matters before investing And taking any decision. We are not responsible for any profit/loss you made. Request your support and engagement by liking and commenting & follow to provide encouragement HAPPY TRADING 👍
NSE:GTLINFRALong
by Jagadheesh_JP
GG ENGINEERING LTD - BEST GROWING PENNY STOCKCan Enter at CMP 2.58 or Wait for 3.15 level Targets - 5,6.84,8.20+ Disclaimer - All information on this page is for educational purposes only, we are not SEBI Registered, Please consult a SEBI registered financial advisor for your financial matters before investing And taking any decision. We are not responsible for any profit/loss you made. Request your support and engagement by liking and commenting & follow to provide encouragement HAPPY TRADING 👍
BSE:GGENGLong
by Jagadheesh_JP
HRTX a biotech penny stock with 70% in two months LONGHRTX has been suggested by various trading websites as a potentially explosive penny biotech stock for 2024. It has experienced excellent price actions since an earnings beat in November. It beat the estimates; that is to say it burned about half as much cash as the analysts estimated the it would. Today it pumped 11%. Relevant articles can be found compiled on the Yahoo Finance page linked here. The chart is 120 minutes. A alpha trend indicator is shown and the supertrend since the November earnings is upward. An AI Lorentzian indicator is added with a 2000 candle lookback to generate buy and sell signals. It calculated a 59% win on 83 trades over those 2000 candles two hours each; this amounts to about 2000 x 2 / 6 hrs per session or more than 600 trading days = 2 1/2 years. Also supporting an entry at this time is the faster (45 min) RSI line rising over the 50 level while the slower ( 240 minutes in red) RSI line has been over the 50 level since those earnings. The ADX indicator had a DI- and DI + flip with a mini pullback to close out last week's trading ( profit taking). The volatility indicator also showed that dip with selling volatility greater than buying which has now flipped. Given that price has went 5X in 2 months , there is a possibility HRTX is overbought. Analysts seem to think otherwise. I will take a stock position here and anticipate holding the position into the next earnings. For trade management I will take partials of 5 % each at the high of day for ten days going into earnings and hold the remaining 50% through the earnings. In the meanwhile I will review the trade if the machine-learning alo indicator generates either a buy or sell signal. For those lacking the risk tolerance for money-losing biotechnology penny stocks with high potential but are aware that biotechnology is expected to be "outperforming" in 2024, XBI and LABU are ETFs with risk-mitigation in the form of a diverse portfolio from the sector.
NASDAQ:HRTXLong
by AwesomeAvani
UROY Short Sell Trade from High Tight Flag Breakdown SHORTUROY topped out as shown by my other ideas. Profits are redeployed into it in a short trade to play the volatility. Expect 10% in 1-3 days. Text box comments are on the chart. The volatility is increased;the uranium sector is hot ( no pun here) given the climate warming and t the ongoing debates on fossil fuels and government initiatives supporting green energy and trying to wean the oil addiction. ( ZOOM out and to the left for text comments )
NASDAQ:UROYShort
by AwesomeAvani
An In-Depth Analysis of Cars.com (NYSE:CARS) Post Q3 EarningsCars.com (NYSE: NYSE:CARS ) has emerged as a digital hub connecting new and used car buyers and sellers. As we delve into the aftermath of the Q3 earnings report, it becomes clear that Cars.com is at a crossroads, navigating challenges but also seizing strategic opportunities for future growth. Marketplace Resilience Amid Q3 Slowdown: The broader online marketplace sector faced headwinds in Q3, with revenues beating analyst estimates by a modest 1.8%, while next quarter's revenue guidance lagged by 1.7%. However, Cars.com demonstrated resilience in the face of this trend. Despite a weaker quarter, the company's share prices rose by 4.6% on average since the previous earnings results, outperforming other cash-burning entities. Q3 Performance and Strategic Moves: Cars.com reported Q3 revenues of $174.3 million, a 5.9% YoY increase, in line with analyst expectations. The quarter, however, witnessed a decline in the user base and slow revenue growth. Despite these challenges, the company made strategic moves to fortify its position in the market. Notably, the launch of Cars Commerce, a new B2B brand, reflects a commitment to simplifying the car buying and selling process for all stakeholders. CEO Alex Vetter emphasized the strategic importance of this move, stating, "During the quarter, we made strong strategic moves that advanced our platform strategy and unlocked future growth." Acquisition and Geographic Expansion: Cars.com's acquisition of D2C Media Inc. is a noteworthy development, extending its presence in the Canadian market and unlocking new growth opportunities. This move aligns with the company's broader strategy of uniting the industry and fostering a seamless experience for consumers, dealers, OEMs, and lenders. User Base Dynamics: The Q3 report indicated a decline in the user base, with 18.7 thousand active buyers, down 4.44% YoY. While this is a notable setback, the company's focus on strategic initiatives and the launch of Cars Commerce could potentially reverse this trend in the coming quarters. Future Outlook: As the stock currently trades at $17.17, reflecting a 15.88% increase since the results, investors are cautiously optimistic. The success of Cars.com in the coming quarters will depend on its ability to capitalize on the launched initiatives, navigate challenges in the online marketplace sector, and harness the potential unlocked by the acquisition of D2C Media Inc. Conclusion: Cars.com ( NYSE:CARS ) stands at a pivotal juncture, having weathered the storms of a challenging Q3 while strategically positioning itself for future growth. The launch of Cars Commerce, the acquisition of D2C Media Inc., and the commitment to industry unification underscore a resilient strategy. Investors will be closely watching how Cars.com steers through the road ahead, making this digital marketplace a compelling stock to watch in the coming months.
NYSE:CARS
by DEXWireNews